Michael Croft

23PUBLICATIONS
56CO-AUTHORS
Predictive and prognostic markersAllergyAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Nov 26, 2024
Comparison of CD30L and OX40L Reveals CD30L as a Promising Therapeutic Target in Atopic Dermatitis.

Rinkesh K Gupta, Daniela Salgado Figueroa, Ferhat Ay

|Oct 25, 2024
Targeting the TNF and TNFR superfamilies in autoimmune disease and cancer.

Michael Croft, Shahram Salek-Ardakani, Carl F Ware

|Feb 10, 2024
Correction to: OX40 in the Pathogenesis of Atopic Dermatitis-A New Therapeutic Target.

Michael Croft, Ehsanollah Esfandiari, Camilla Chong

|Jan 18, 2024
OX40 in the Pathogenesis of Atopic Dermatitis-A New Therapeutic Target.

Michael Croft, Ehsanollah Esfandiari, Camilla Chong

Pageof 4